Confining cell-killing treatments to tumors
Attaching a Velcro-like molecule may prevent immune proteins called cytokines from leaking out of cancerous tissue after injection.
Attaching a Velcro-like molecule may prevent immune proteins called cytokines from leaking out of cancerous tissue after injection.
Crystallized drug prevents immune system rejection of transplanted pancreatic islet cells.
Compound that knocks out a DNA repair pathway enhances cisplatin treatment and helps prevent drug-resistance.
Through computing, senior and Marshall Scholar Anna Sappington seeks answers to biological questions.
Institute professor is honored for transformative work in drug delivery and tissue engineering.
A study of prostate cancer finds “aneuploid” tumors are more likely to be lethal than tumors with normal chromosome numbers.
Three MIT undergraduates honored for their academic achievements.
Convergence research at MIT and beyond seeks new solutions for global challenges.
Researchers develop nanosized antibodies that home in on the meshwork of proteins surrounding cancer cells.
Faculty members Edward Boyden, Paula Hammond, and Aviv Regev recognized for “distinguished and continuing achievements in original research.”
Eight biology contestants get one slide and three minutes to explain their research and impress their listeners.
Tiny robots powered by magnetic fields could help drug-delivery nanoparticles reach their targets.
More effective surgery could boost survival rates for ovarian cancer.
The substance that bathes tumors in the body is quite different from the medium used to grow cancer cells in the lab, biologists report.
Foundation’s $28.6 million gift will fund science, innovation, and education to advance understanding, ability, and inclusion.